MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

NATerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 8, 2016

Primary Completion Date

March 13, 2020

Study Completion Date

March 13, 2020

Conditions
Lung NeoplasmsCancer of LungCancer of the LungLung CancerNeoplasms, LungNeoplasms, PulmonaryPulmonary CancerPulmonary NeoplasmsMetastatic Cancer to the Lung
Interventions
PROCEDURE

Microwave ablation

Microwave tumor ablation is a procedure that uses heat made by an electric current to destroy a tumor (ablation). With imaging equipment, such as ultrasound or CT (computed tomography), and a small incision made in the skin, the tumor is located and treated with radiofrequency energy. The cells that are killed by the microwave ablation are typically not removed but are eventually replaced by fibrosis and scar tissue.

Trial Locations (2)

55901

Mayo Clinic, Rochester

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic - MITG

INDUSTRY

lead

Mayo Clinic

OTHER

NCT02673021 - MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) | Biotech Hunter | Biotech Hunter